Skip to main content
. 2020 May 19;10:715. doi: 10.3389/fonc.2020.00715

Table 1.

Baseline clinical characteristics of lung cancer patients in SEER database.

Characteristics Bone metastasis Brain metastasis Liver metastasis DL metastasis
No (%) Yes (%) P No (%) Yes (%) P No (%) Yes (%) P No (%) Yes (%) P
Histological type
   Adenocarcinoma 59,090 (78.5) 16,141 (21.5) <0.001 63,943 (85.0) 11,288 (15.0) <0.001 68,647 (91.2) 6,584 (8.8) <0.001 70,399 (93.6) 4,832 (6.4) <0.001
   Squamous cell carcinoma 33,033 (88.8) 4,146 (11.2) 35,061 (94.3) 2,118 (5.7) 34,874 (93.8) 2,305 (6.2) 35,737 (88.0) 1,442 (12.0)
   LCLC 2,322 (82.0) 510 (18.0) 2,342 (82.7) 490 (17.3) 2,441 (86.2) 391 (13.8) 2,601 (91.8) 231 (8.2)
   SCLC 17,427 (76.7) 5,282 (23.3) 18.913 (83.3) 3,796 (16.7) 15,549 (68.5) 7,160 (31.5) 20,308 (89.4) 2,401 (10.6)
   NSCLC/NOS 16,749 (78.7) 4,541 (21.3) 17,736 (83.3) 3,554 (16.7) 18,341 (86.1) 2,949 (13.9) 19,803 (93.0) 1,487 (7.0)
Gender
   Male 66,188 (79.2) 17,382 (20.8) <0.001 72,491 (86.7) 11,079 (13.3) 0.295 72,929 (87.3) 10,641 (12.7) <0.001 77,683 (93.0) 5,887 (7.0) <0.001
   Female 62,433 (82.5) 13,238 (17.5) 65,504 (86.6) 10,167 (13.4) 66,923 (88.4) 8,748 (11.6) 71,165 (94.0) 4,506 (6.0)
Age
    <50 5,129 (74.9) 1,717 (25.1) <0.001 5,361 (78.3) 1,485 (21.7) <0.001 5,936 (86.7) 910 (13.3) <0.001 6,156 (89.9) 690 (10.1) <0.001
   51–65 39,240 (77.7) 11,276 (22.3) 41,365 (81.9) 9,151 (18.1) 43,568 (86.2) 6,948 (13.8) 46,254 (91.6) 4,262 (8.4)
   ≥65 84,252 (82.7) 17,627 (17.3) 91,269 (89.6) 10610 (10.4) 90,348 (88.7) 11,531 (11.3) 96,438 (94.7) 5,441 (5.3)
Marital status
   Married 62,526 (79.8) 15,860 (20.2) <0.001 67,634 (86.3) 10,752 (13.7) <0.001 68,786 (87.8) 9,600 (12.2) 0.625 73,147 (93.3) 5,239 (6.7) 0.035
   Unmarried 60,049 (81.7) 13,420 (18.3) 63,833 (86.9) 9,636 (13.1) 64,562 (87.9) 8,907 (12.1) 68,772 (93.6) 4,697 (6.4)
   Unknown 6,046 (81.9) 1,340 (18.1) 6,528 (88.4) 858 (11.6) 6,504 (88.1) 882 (11.9) 6,929 (93.8) 457 (6.2)
Race
   White 103,885 (80.9) 24,502 (19.1) <0.001 111,722 (87.0) 16,665 (13.0) <0.001 112,357 (87.5) 16,030 (12.5) <0.001 120,108 (93.6) 8,279 (6.4) 0.009
   Black 15,612 (81.5) 3,555 (18.5) 16,447 (85.8) 2,720 (14.2) 17,055 (89.0) 2,112 (11.0) 17,889 (93.3) 1,278 (6.7)
   Others 9,124 (78.1) 2,563 (21.9) 9,826 (84.1) 1,861 (15.9) 10,440 (89.3) 1,247 (10.7) 10,851 (92.8) 836 (7.2)
Grade
   I 7,240 (94.3) 434 (5.7) <0.001 7,405 (96.5) 269 (3.5) <0.001 7,521 (98.0) 153 (2.0) <0.001 7,573 (98.7) 101 (1.3) <0.001
   II 23,464 (90.6) 2,444 (9.4) 24,237 (93.6) 1,671 (6.4) 25,041 (96.7) 867 (3.3) 25,312 (97.7) 596 (2.3)
   III 33,521 (83.9) 6,441 (16.1) 34,842 (87.2) 5,120 (12.8) 36,528 (91.4) 3,434 (8.6) 37,754 (94.5) 2,208 (5.5)
   IV 3,901 (80.4) 951 (19.6) 4,121 (84.9) 731 (15.1) 3,836 (79.1) 1,016 (20.9) 4,434 (91.4) 418 (8.6)
   Unknown 60,495 (74.8) 20,350 (25.2) 67,390 (83.4) 13,455 (16.6) 66,926 (82.8) 13,919 (17.2) 73,775 (91.3) 7,070 (8.7)
Size (cm)
    <2.0 17,612 (89.1) 2,160 (10.9) <0.001 18,206 (92.1) 1,566 (7.9) <0.001 18,536 (93.7) 1,236 (6.3) <0.001 19,025 (96.2) 747 (3.8) <0.001
   2.0–4.9 51,049 (82.2) 11,029 (17.8) 54,351 (87.6) 7,727 (12.4) 55,967 (90.2) 6,111 (9.8) 58,838 (94.8) 3,240 (5.2)
   5.0–9.9 32,257 (79.1) 8,511 (20.9) 34,305 (84.1) 6,463 (15.9) 35,269 (86.5) 5,499 (13.5) 37,835 (92.8) 2,933 (7.2)
   ≥10.0 3,844 (79.8) 974 (20.2) 4,067 (85.4) 751 (15.6) 4,123 (85.6) 695 (14.4) 4,383 (91.0) 435 (9.0)
   Unknown 23,859 (75.0) 7,946 (25.0) 27,066 (85.1) 4,739 (14.9) 25,957 (81.6) 5,848 (18.4) 28,767 (90.4) 3,038 (9.6)
Regional lymph node invasion
   N0 53,156 (90.4) 5,630 (9.6) <0.001 54,430 (92.6) 4,356 (7.4) <0.001 55,846 (95.0) 2,940 (5.0) <0.001 57,998 (98.7) 788 (1.3) <0.001
   N1 10,999 (82.5) 2,337 (17.5) 11,604 (87.0) 1,732 (13.0) 11,952 (89.6) 1,384 (10.4) 12,824 (96.2) 512 (3.8)
   N2 44,427 (75.6) 14,321 (24.4) 48,970 (83.4) 9,778 (16.6) 48,861 (83.2) 9,887 (16.8) 54,392 (92.6) 4,356 (7.4)
   N3 15,408 (70.4) 6,479 (29.6) 17,707 (80.9) 4,180 (19.1) 18,009 (82.3) 3,878 (17.7) 17,249 (79.6) 4,458 (20.4)
   NX 4,631 (71.4) 1,853 (28.6) 5,284 (81.5) 1,200 (18.5) 5,184 (80.0) 1,300 (20.0) 6,205 (95.7) 279 (4.3)
Surgery
   Yes 32,518 (98.8) 400 (1.2) <0.001 32,346 (98.3) 572 (1.7) <0.001 32,760 (99.5) 158 (0.5) <0.001 32,783 (99.6) 135 (0.4) <0.001
   No 96,103 (76.1) 30,220 (23.9) 105,649 (83.6) 20,674 (16.4) 107,092 (84.8) 19,231 (15.2) 116,065 (91.9) 10,258 (8.1)
Chemotherapy
   Yes 58,803 (77.5) 17,117 (22.5) <0.001 64,268 (84.7) 11,652 (15.3) <0.001 65,583 (86.4) 10,337 (13.6) <0.001 69,507 (91.6) 6,413 (8.4) <0.001
   No 69,818 (83.8) 13,503 (16.2) 73,727 (88.5) 9,594 (11.5) 74,269 (89.1) 9,052 (10.9) 79,341 (95.2) 3,980 (4.8)
Radiation therapy
Yes 50,966 (76.8) 15,387 (23.2) <0.001 50,744 (76.5) 15,609 (23.5) <0.001 59,939 (90.3) 6,414 (9.7) <0.001 62,016 (93.5) 4,337 (6.5) 0.895
No 77,655 (83.6) 15,233 (16.4) 87,251 (93.9) 5,637 (6.1) 79,913 (86.0) 12,975 (14.0) 86,832 (93.5) 6,056 (6.5)

ΔOthers include American Indian, AK Native, Asian, and Pacific Islander. LCLC, Large-cell lung cancer; SCLC, Small-cell lung cancer; NSCLC, Non-small cell lung cancer.